JP2012533554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012533554A5 JP2012533554A5 JP2012520770A JP2012520770A JP2012533554A5 JP 2012533554 A5 JP2012533554 A5 JP 2012533554A5 JP 2012520770 A JP2012520770 A JP 2012520770A JP 2012520770 A JP2012520770 A JP 2012520770A JP 2012533554 A5 JP2012533554 A5 JP 2012533554A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- olopatadine
- period
- phosphate
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims description 46
- 229960004114 olopatadine Drugs 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000007922 nasal spray Substances 0.000 claims description 18
- 229940097496 nasal spray Drugs 0.000 claims description 18
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 14
- 239000003002 pH adjusting agent Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 10
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 9
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 9
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 9
- 239000012458 free base Substances 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000001177 diphosphate Substances 0.000 claims description 5
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 5
- 235000011180 diphosphates Nutrition 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 5
- BDRTVPCFKSUHCJ-UHFFFAOYSA-N molecular hydrogen;potassium Chemical compound [K].[H][H] BDRTVPCFKSUHCJ-UHFFFAOYSA-N 0.000 claims description 5
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 5
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 5
- 239000001488 sodium phosphate Substances 0.000 claims description 5
- 229910000404 tripotassium phosphate Inorganic materials 0.000 claims description 5
- 235000019798 tripotassium phosphate Nutrition 0.000 claims description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 5
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 5
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 229940127557 pharmaceutical product Drugs 0.000 claims description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22646909P | 2009-07-17 | 2009-07-17 | |
| US61/226,469 | 2009-07-17 | ||
| PCT/US2010/042085 WO2011008923A2 (en) | 2009-07-17 | 2010-07-15 | Olopatadine nasal spray regimen for children |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012533554A JP2012533554A (ja) | 2012-12-27 |
| JP2012533554A5 true JP2012533554A5 (enExample) | 2013-08-08 |
Family
ID=42664656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012520770A Pending JP2012533554A (ja) | 2009-07-17 | 2010-07-15 | 小児のためのオロパタジン経鼻噴霧剤レジメン |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20110011392A1 (enExample) |
| EP (1) | EP2453872B1 (enExample) |
| JP (1) | JP2012533554A (enExample) |
| KR (1) | KR20120046215A (enExample) |
| CN (2) | CN102470099A (enExample) |
| AU (1) | AU2010273347B2 (enExample) |
| BR (1) | BR112012001169A2 (enExample) |
| CA (1) | CA2768006A1 (enExample) |
| DK (1) | DK2453872T3 (enExample) |
| ES (1) | ES2432502T3 (enExample) |
| HR (1) | HRP20130946T1 (enExample) |
| MX (1) | MX2012000539A (enExample) |
| PL (1) | PL2453872T3 (enExample) |
| PT (1) | PT2453872E (enExample) |
| SI (1) | SI2453872T1 (enExample) |
| WO (1) | WO2011008923A2 (enExample) |
| ZA (1) | ZA201109320B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| RU2686670C2 (ru) | 2013-10-04 | 2019-04-30 | Гленмарк Спешиалити С.А. | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN107569454B (zh) * | 2017-09-29 | 2018-05-04 | 深圳大佛药业股份有限公司 | 一种盐酸奥洛他定鼻喷雾剂及其制备方法 |
| MX2020008741A (es) | 2018-02-23 | 2020-09-28 | Glenmark Specialty Sa | Tratamiento de la rinitis alergica en sujetos pediatricos con una combinacion de mometasona y olopatadina. |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN109806224B (zh) * | 2019-03-15 | 2021-05-28 | 江苏长泰药业有限公司 | 一种奥洛他定组合物及其制备方法 |
| WO2021158736A1 (en) * | 2020-02-06 | 2021-08-12 | Corbett Lair, Inc. | Method, apparatus and kit for treating chronic and long-term nasal congestion |
| WO2025137749A1 (pt) * | 2023-12-27 | 2025-07-03 | Eurofarma Laboratórios S.A. | Processo de solubilização de olopatadina e seu uso |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| SE8704767L (sv) * | 1987-11-30 | 1989-05-31 | Sigmund Johannes Loefstedt | Ny metod foer administrering av laekemedel |
| US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| JP2005281315A (ja) * | 1997-07-02 | 2005-10-13 | Aventis Pharmaceuticals Holdings Inc | 水性薬理組成物 |
| GB9918559D0 (en) * | 1999-08-07 | 1999-10-06 | Glaxo Wellcome Kk | Novel pharmaceutical formulation |
| GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| US7977376B2 (en) * | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| US20040214754A1 (en) * | 2001-10-03 | 2004-10-28 | Ellis Edward J. | Ophthalmic preparation containing glycomacropeptide |
| US20030004179A1 (en) * | 2002-05-21 | 2003-01-02 | Affrime Melton B | Treating allergic and inflammatory conditions |
| MXPA05008718A (es) * | 2003-02-17 | 2005-09-20 | Sun Pharmaceutical Ind Ltd | Una composicion de corticosteroide de dosis baja. |
| AU2005309951B2 (en) * | 2004-11-24 | 2011-07-07 | Alcon, Inc. | Method of delivering nasal spray |
| HUE026162T2 (en) * | 2007-02-07 | 2016-05-30 | Novartis Ag | Olopatadine preparation for topical nasal administration |
-
2010
- 2010-07-15 PT PT107351306T patent/PT2453872E/pt unknown
- 2010-07-15 DK DK10735130.6T patent/DK2453872T3/da active
- 2010-07-15 KR KR1020127002796A patent/KR20120046215A/ko not_active Ceased
- 2010-07-15 AU AU2010273347A patent/AU2010273347B2/en not_active Ceased
- 2010-07-15 US US12/836,834 patent/US20110011392A1/en not_active Abandoned
- 2010-07-15 SI SI201030341T patent/SI2453872T1/sl unknown
- 2010-07-15 WO PCT/US2010/042085 patent/WO2011008923A2/en not_active Ceased
- 2010-07-15 CN CN2010800323582A patent/CN102470099A/zh active Pending
- 2010-07-15 CA CA2768006A patent/CA2768006A1/en not_active Abandoned
- 2010-07-15 JP JP2012520770A patent/JP2012533554A/ja active Pending
- 2010-07-15 EP EP10735130.6A patent/EP2453872B1/en not_active Not-in-force
- 2010-07-15 PL PL10735130T patent/PL2453872T3/pl unknown
- 2010-07-15 MX MX2012000539A patent/MX2012000539A/es active IP Right Grant
- 2010-07-15 HR HRP20130946AT patent/HRP20130946T1/hr unknown
- 2010-07-15 CN CN201410246743.7A patent/CN104173273A/zh active Pending
- 2010-07-15 ES ES10735130T patent/ES2432502T3/es active Active
- 2010-07-15 BR BR112012001169A patent/BR112012001169A2/pt not_active IP Right Cessation
-
2011
- 2011-12-19 ZA ZA2011/09320A patent/ZA201109320B/en unknown
-
2013
- 2013-09-10 US US14/022,528 patent/US20140007865A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012533554A5 (enExample) | ||
| HRP20130946T1 (hr) | Olopatadin nazalni sprej, namijenjen upotrebi kod djece | |
| HRP20120147T1 (hr) | Titracija tapentadola | |
| ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
| JP2009137970A (ja) | ミルタザピンと１種類以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物 | |
| BR0313139A (pt) | Métodos e formas de dosagem para fornecimento controlado de paliperidona | |
| JP2010531879A5 (enExample) | ||
| WO2003065982A3 (en) | Engineering absorption of therapeutic compounds via colonic transporters | |
| JP2011051993A5 (enExample) | ||
| CA2671470A1 (en) | Powder formulation for valganciclovir | |
| JP6574809B2 (ja) | 慢性疲労の治療用の組成物および方法 | |
| Sodagar et al. | Effect of nicotine on orthodontic tooth movement in rats | |
| CN101636159A (zh) | 用于预防和治疗阿尔茨海默型痴呆症的药物 | |
| JP2011512394A5 (enExample) | ||
| JP2015520229A (ja) | 神経心理学的障害の治療用の組成物および方法 | |
| WO2011031890A4 (en) | Cancer stem cell-targeted and drug resistant cancer therapy | |
| JPH08511253A (ja) | アンギオテンシン変換酵素阻害剤とａ▲ｉｉ▼アンタゴニストとの組み合わせ | |
| JP2015521647A5 (enExample) | ||
| TW200517127A (en) | Novel composition | |
| WO2000056295A2 (en) | Oral combinations of hydroxocobalamin and folic acid | |
| CN1384104A (zh) | 使用吡咯衍生物的方法、试剂盒和组合物 | |
| GT200000087A (es) | Formas polimorfas de un citrato de azabiciclo(2.2.2) octan - 3 - amina y sus composiciones farmaceuticas. | |
| MX2021003668A (es) | Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. | |
| JPWO2022111858A5 (enExample) | ||
| EP1518554B1 (en) | Pharmaceutical composition for the treatment of hyperhomocysteinemia |